US2010279365A1PendingUtilityA1

Novel aldolase and production process of substituted alpha-keto acids

Assignee: AJINOMOTO KKPriority: Aug 26, 2002Filed: Nov 6, 2009Published: Nov 4, 2010
Est. expiryAug 26, 2022(expired)· nominal 20-yr term from priority
C12P 17/10C12P 7/42C12P 7/50C12P 13/04C12N 9/88C12N 15/11C12N 15/52
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

4-(indol-3-ylmethyl)-4-hydroxy-2-oxoglutarate, which is useful as an intermediate in the synthesis of monatin, may be synthesized from indole pyruvic acid and pyruvic acid (and/or oxaloacetic acid) by using a novel aldolase derived from the genus Pseudomonas, Erwinia, Flavobacterium, or Xanthomonas.

Claims

exact text as granted — not AI-modified
1 .- 24 . (canceled) 
     
     
         25 . A process of producing monatin represented by formula (5) 
       
         
           
           
               
               
           
         
       
       comprising:
 reacting indole pyruvic acid with oxaloacetic acid or pyruvic acid in the presence of a protein having aldolase activity to obtain 4-(indol-3-ylmethyl)-4-hydroxy-2-oxoglutarate represented by formula (4) 
 
       
         
           
           
               
               
           
         
         and converting said 4-(indol-3-ylmethyl)-4-hydroxy-2-oxoglutarate represented by formula (4) to monatin. 
       
     
     
         26 . The process of  claim 25 , wherein said protein having aldolase activity is comprised in a culture comprising microbial cells. 
     
     
         27 . The process of  claim 25 , wherein said protein having aldolase activity is comprised in microbial cells. 
     
     
         28 . The process of  claim 25 , wherein said protein having aldolase activity is comprised in a culture medium in which microbial cells have been removed. 
     
     
         29 . The process of  claim 25 , wherein said protein having aldolase activity is comprised in a treated microbial cell product that have been disrupted or lysed. 
     
     
         30 . The process of  claim 25 , wherein said protein having aldolase activity is in a purified form.

Join the waitlist — get patent alerts

Track US2010279365A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.